Aarti Pharmalabs Ltd. – Signs of Exhaustion with CMF Weakness
AARTIPHARM
🔍 Key Technical Observations:
Long-Term Uptrend:
The stock has been moving steadily inside a broad ascending channel.
Multiple higher highs and higher lows support the bullish structure.
Exhaustion Near Channel Top:
Price recently touched the upper boundary of the channel and showed signs of immediate rejection.
The current pullback suggests potential short-term exhaustion.
Volume Insights:
Volume spiked on the recent breakout but tapered during the current pullback.
Lighter volume during the correction may suggest a healthy pause, but needs monitoring.
Chaikin Money Flow (CMF) Drop:
CMF is falling despite the price staying elevated.
This indicates weakening buying pressure and potential distribution at higher levels.
Key Support Zones:
Immediate support at ₹773.05.
Stronger support at ₹692.05, aligned with mid-channel levels.
Short-Term Outlook:
Pullback likely to continue unless strong buying emerges near the ₹850–₹860 zone.
Sustained weakness in CMF could lead to deeper consolidation toward ₹773.
👉 Summary:
The stock is structurally bullish long-term, but short-term signals (price rejection + CMF drop) suggest caution.
Watch for price action around ₹773–₹850 for the next move.
📢 Disclaimer:
This is for informational purposes only. Not a buy/sell recommendation. Positions may or may not be held.
🧑💼 Rajneesh Sharma is a SEBI-registered Research Analyst (INH000020332).
📄 Investments are subject to market risks. Read all related documents carefully.